Welcome to LookChem.com Sign In|Join Free

CAS

  • or

76843-23-7

Przewaquinone A is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

76843-23-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 76843-23-7 Structure

  • Basic information

    1. Product Name: Przewaquinone A
    2. Synonyms: Przewaquinone A;6,7,8,9-Tetrahydro-1-(hydroxymethyl)-6,6-dimethylphenanthro[1,2-b]furan-10,11-dione
    3. CAS NO:76843-23-7
    4. Molecular Formula: C19H18O4
    5. Molecular Weight: 310.34382
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 76843-23-7.mol

  • Chemical Properties

    1. Melting Point: 171-173℃
    2. Boiling Point: 430.4±40.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.288±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: 13.19±0.10(Predicted)
    10. CAS DataBase Reference: Przewaquinone A(CAS DataBase Reference)
    11. NIST Chemistry Reference: Przewaquinone A(76843-23-7)
    12. EPA Substance Registry System: Przewaquinone A(76843-23-7)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 76843-23-7(Hazardous Substances Data)

76843-23-7 Usage

Cytotoxicity

IC50 (μg/mL): 0.77 (5637), 1.73 (A-427),0.34 (MCF-7) (Mothana et al. 2009)IC50 (μg/mL): 2.3 (Hep-2), 1.7 (A549), 1.9(SK-OV-3), 1.6 (SK-MEL-2) 0.8 (XF498)(Wang et al. 2007), IC50 (μg/mL): 23(P-388) (Zhao et al. 2011)IC50 (μg/mL): 2.3 (A549), 1.7 (SK-OV-3),1.9 (SK-MEL-2), 1.96 (XF498), 0.8(HCT15) (Zhang et al. 2013)

Check Digit Verification of cas no

The CAS Registry Mumber 76843-23-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,6,8,4 and 3 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 76843-23:
(7*7)+(6*6)+(5*8)+(4*4)+(3*3)+(2*2)+(1*3)=157
157 % 10 = 7
So 76843-23-7 is a valid CAS Registry Number.

76843-23-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name Przewaquinone A

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:76843-23-7 SDS

76843-23-7Upstream product

76843-23-7Downstream Products

76843-23-7Relevant articles and documents

New application of tanshinone IIA derivatives as MAGL (monoacylglycerol lipase) inhibitor

-

Paragraph 0012; 0029, (2017/09/12)

The invention relates to the field of pharmaceutical chemistry, specifically to medical application of tanshinone IIA derivatives (I) and (II). Pharmacological experiments show that the compound has strong monoacylglycerol lipase inhibitory activity and good analgesic activity. The compound is expected to be used for developing a novel analgesic drug based on the clinic use of a monoacylglycerol lipase inhibitor.

Radix Salviae Miltiorrhizae ketone compound, preparation method and its use (by machine translation)

-

Paragraph 0107-0109, (2016/10/10)

The invention provides tanshinone compounds, a preparation method and use thereof, and relates to the technical field of pharmaceutical chemistry. The tanshinone compounds possess a structure formula I or II as shown in the specification. The use of the tanshinone compounds includes but not limited to anticancer drugs, particularly the treatment of prostate cancer and bladder cancer, and induction of androgen receptor antagonist activity when patients have androgen-related diseases, wherein the androgen-related diseases include but not limited to multi-disease, acne, and spermatogenesis without inhibition in need of suppressing spermatogenesis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 76843-23-7